AMPH Forecast and Technical Stock Analysis
Sell candidate since 2019-09-18 Loss -2.31% PDF
Amphastar Pharmaceuticals fell by -1.14% in the last day ( Friday, 20th Sep 2019 ) from $20.97 to $20.73 and has now fallen 5 days in a row. During the day the stock fluctuated 3.13% from a day low at $20.57 to a day high of $21.21. The price has fallen in 7 of the last 10 days and is down by -4.12% for this period. Volume has increased in the last day by 481 922 shares but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 662 511 shares bought and sold for approximately $13.73 million.
- 30 day high of the AMPH stock price was $22.85 and low was $20.57.
- 90 day high was $22.85 and low was $18.66.
- 52 week high for Amphastar Pharmaceuticals - $25.43 and low - $17.71.
Amphastar Pharmaceuticals lies in the lower part of a wide and weak rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $20.32 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 8.52% during the next 3 months and, with 90% probability hold a price between $22.05 and $25.21 at the end of this period.
There are few to none technical positive signals at the moment. Amphastar Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $21.37 and $21.39. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Wednesday September 11, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 32 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Amphastar Pharmaceuticals finds support from accumulated volume at $20.64.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.64 (3.13%) between high and low. For the last week, the stock has had daily average volatility of 2.65%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
2.65 %Average volatility
Very Low Low Medium High Very High
The Amphastar Pharmaceuticals stock holds several negative signals and despite the positive trend we believe Amphastar Pharmaceuticals will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
|AMPH $20.73 ($-0.24 -1.14%)|
AMPH is down $0.24 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AMPH based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AMPH analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!